Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Univentricular Heart
- Fontan Udenafil Exercise Longitudinal Assessment Trial - 2
- Fibrosis and the Fontan
- Aesculus Hippocastanum L. on Fontan Circulation
- Efficacy of Phosphodiesterase-type 5 Inhibitors in Patients With Univentricular Congenital Heart Disease
- Colchicine in Postoperative Fontan Patients
- Early Use of Vasopressin in Post-Fontan Management
- A Extension Study of Udenafil in Adolescents
- Use of Vasopressin Following the Fontan Operation
- Effect of Carvedilol on Exercise Performance in Fontan Patients
- Fontan Udenafil Exercise Longitudinal Assessment Trial
- Perioperative Treprostinil in Pediatric Patients Undergoing the Fontan Operation
- Pharmacokinetic/Pharmacodynamic Study of Udenafil in Adolescents
- Ambrisentan in Single Ventricle
- The Effects of Eplerenone on Markers of Myocardial Fibrosis in Adult Congenital Heart Disease
- The Effects of Ambrisentan on Exercise Capacity in Fontan Patients
- Bosentan Therapy in Children With Functional Single Ventricle
- Effect of Tadalafil on Exercise Capacity in Pediatric Fontan Patients
- Sildenafil in Single Ventricle Patients
- Pilot/Ph I Safety and Efficacy of ODSH in Protein Losing Enteropathy Secondary to Single Ventricle Palliative Surgery
- Endothelin Blockade in Patients With Single Ventricle Physiology
- Pathophysiological Mechanisms of Hepatopulmonary Influence in the Fontan Circulation
- Spironolactone in Patients With Single Ventricle Heart
- Trial of Angiotensin Converting Enzyme Inhibition in Infants With Single Ventricle--Pediatric Heart Network